Skip to main content
. 2022 Feb 21;21:57. doi: 10.1186/s12943-022-01518-8

Fig. 6.

Fig. 6

The structure of CARs and the application of CRISPR/Cas9 in CAR-T cell therapy. a The structure of the first to third generation CARs. b Knock-out of endogenous TCR sites, immune checkpoint protein and major histocompatibility complex class I molecules generates universal CAR-T cells to enhance T cell killing and avoid graft-versus-host disease